Upper Airways Research Laboratory (URL)

Background and research focus

Background

The Upper Airways Research Laboratory (URL) is a leading translational research group within the Department of Head and Skin at Ghent University. Founded in 1997 by Prof. Claus Bachert, the laboratory has developed into an internationally recognized center of excellence in airway immunology, allergy and chronic inflammatory diseases of the upper airways. 

Today, the laboratory is led by Prof. Philippe Gevaert and Prof. Stijn Vanhee and brings together clinicians, immunologists and biomedical scientists to investigate the mechanisms underlying chronic airway inflammation. The research programme integrates fundamental immunology, advanced molecular technologies and patient-oriented clinical research to translate scientific discoveries into improved diagnostics and innovative therapies. 

The URL is embedded within the Ghent University Allergy Network, founded by Prof. Philippe Gevaert in 2008, which promotes multidisciplinary collaborations across research groups working in allergy, immunology and inflammatory diseases.

Research focus

The Upper Airways Research Laboratory investigates the cellular and molecular mechanisms driving chronic inflammatory diseases of the upper and lower airways. By combining human tissue studies, ex vivo disease models, advanced immunological techniques and translational patient research, we aim to bridge fundamental discoveries and clinical applications.

Our research focuses on:

  • Chronic rhinosinusitis with and without nasal polyps
  • Allergic rhinitis and allergic airway disease
  • Type 2 inflammation and eosinophilic disorders
  • B-cell biology, local antibody responses and tissue immunology
  • Mucosal immune mechanisms in airway inflammation
  • Biomarker discovery and disease endotyping
  • Precision medicine approaches for chronic airway diseases
  • Mechanisms of action and optimization of biological therapies and allergen immunotherapy

The disease burden of patients remains central to our mission. We seek to understand disease mechanisms, identify clinically relevant disease endotypes, discover novel therapeutic targets and translate these findings into investigator-driven and industry-sponsored clinical trials. Through close collaboration with the Clinical Trial Center and international research networks, the URL contributes to the development of next-generation treatments for patients with chronic inflammatory airway diseases.

Members

Professors

Philippe Gevaert 

Stijn Vanhee (contact person)

Thibaut Van Zele

Guest Professor

Peter Hellings

Postdoctoral researchers

PhD candidates

Manon Blauwblomme

Pauline Janssens

Ellen ketelaere

Inés Lammens (Department of Internal Medicine and Pediatrics)

Michiel Syssauw

Elke Vandewalle

Technical staff

Natalie De Ruyck

Gabriële Holtappels

National and international collaborations

The Upper Airways Research Laboratory is embedded in a strong national and international network of academic, clinical and industrial collaborators. Through longstanding partnerships with leading research groups in immunology, allergy, respiratory medicine and rhinology, the laboratory contributes to multidisciplinary research aimed at improving the understanding and treatment of chronic inflammatory airway diseases. 

The laboratory collaborates closely with research groups within Ghent University and VIB, as well as with academic partners across Europe and beyond. These collaborations support studies in airway immunology, mucosal inflammation, B-cell biology, allergy, chronic rhinosinusitis, biomarker discovery and precision medicine. The URL is actively involved in international research consortia, investigator-driven studies and multicentre clinical research initiatives focused on innovative therapeutic strategies for patients with chronic airway diseases. 

Through the Ghent University Allergy Network, the laboratory fosters interdisciplinary collaborations connecting basic scientists, translational researchers and clinicians working in allergy and immunology. This environment facilitates the rapid translation of scientific discoveries into clinical applications and patient-centred research programmes.

Funding

Research at the Upper Airways Research Laboratory is supported by competitive national and international funding programmes, including grants from the Research Foundation Flanders (FWO), Ghent University (BOF) and collaborative European research initiatives. These funding programmes support fundamental, translational and clinical research across the spectrum of airway inflammation and allergic disease.

In addition, the laboratory collaborates with pharmaceutical and biotechnology partners in investigator-initiated and industry-sponsored clinical studies. These partnerships contribute to the development and evaluation of novel targeted therapies, biological treatments and precision medicine approaches for chronic inflammatory airway diseases.

Defended PhDs (last 10 years)

Respiratory immunity at the intersection of infection, vaccination and allergy : mechanisms and modulation of type 1 and type 2 inflammation in the upper and lower airways

Jozefien Declercq (2025)

Eosinophilic mucin in chronic rhinosinusitis: clinical implications and long-term outcome

Stephan Vlaminck (2024)

Unraveling Inflammation in Chronic Rhinosinusitis: From Endotyping to Impact of Biologicals

Sharon Van Nevel (2024)

Chronic rhinosinusitis : natural history, impact on health-related quality of life, and patient perspectives   

Asif Hameed Khan (2022)

Treating allergic rhinitis with biologicals: a new therapeutic paradigm?

Jarno De Craemer (2022)

Differentiating neutrophilic and eosinophilic inflammation in chronic rhinosinusitis  

Tim Delemarre (2022)

Optimizing tools for food allergen detection and provocation

Marjolein Vandekerkchove (2019)

Innovative strategies to improve the outcome of medical and surgical treatments in chronic rhinosinusitis with nasal polyps

Els De Schryver (2019)

The interplay of the staphylococcal protease SplD and IL-33 in the development of allergic asthma in mice

Andrea Renate Teufelberger (2018)

The Airway Microbiota: Association with Inflammatory Patterns in Chronic Rhinosinusitis

Thanit Chalermwatanachai (2018)

House dust mite allergic rhinitis : a novel take on diagnosis and treatment

Margot Berings (2018)

Late-onset Inflammatory Airway Disease: from Populations to Endotypes

Peter Tomassen (2017)

The role of viruses and Staphylococcus aureus in propagating a Th2 response in human nasal polyps

Feng Lan (2016)

Immunological consequences of liver transplantation in children: making or breaking tolerance?

Ruth De Bruyne (2015)